Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;90(3):1130-1136.
doi: 10.1002/mrm.29704. Epub 2023 May 24.

Steps on the Path to Clinical Translation: A workshop by the British and Irish Chapter of the ISMRM

Affiliations
Review

Steps on the Path to Clinical Translation: A workshop by the British and Irish Chapter of the ISMRM

Penny L Hubbard Cristinacce et al. Magn Reson Med. 2023 Sep.

Abstract

The British and Irish Chapter of the International Society for Magnetic Resonance in Medicine (BIC-ISMRM) held a workshop entitled "Steps on the path to clinical translation" in Cardiff, UK, on 7th September 2022. The aim of the workshop was to promote discussion within the MR community about the problems and potential solutions for translating quantitative MR (qMR) imaging and spectroscopic biomarkers into clinical application and drug studies. Invited speakers presented the perspectives of radiologists, radiographers, clinical physicists, vendors, imaging Contract/Clinical Research Organizations (CROs), open science networks, metrologists, imaging networks, and those developing consensus methods. A round-table discussion was held in which workshop participants discussed a range of questions pertinent to clinical translation of qMR imaging and spectroscopic biomarkers. Each group summarized their findings via three main conclusions and three further questions. These questions were used as the basis of an online survey of the broader UK MR community.

Keywords: Imaging biomarkers; clinical translation; consensus; quantitative MRI; survey.

PubMed Disclaimer

References

REFERENCES

    1. Shukla-Dave A, Obuchowski NA, Chenevert TL, et al. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2019;49:e101-e121. doi:10.1002/JMRI.26518
    1. de Souza NM, Achten E, Alberich-Bayarri A, et al. European Society of Radiology Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). Insights Imaging. 2019;10:10. doi:10.1186/s13244-019-0764-0
    1. McAteer MA, Koh DM, Leung HY, et al. Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers. 2021;11-14. doi:10.1038/s41416-021-01497-5
    1. Brizmohun Appayya M, Adshead J, Ahmed HU, et al. National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting. BJU Int. 2018;122:13-25. doi:10.1111/BJU.14361
    1. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1- mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69.

LinkOut - more resources